SIR -Your Editorial 'Supporting the future' (Nature 453, 958; 2008) and News Feature 'The research revolution' (Nature 453, 975-976; 2008) rightly point out that the European Research Council (ERC) will change the future of European science funding for the better. But the conclusion that most of the ERC's young-investigator research grants go to the top three of European research -the United Kingdom, France and Germany -disguises a less impressive performance by these countries when the numbers of research grants awarded are considered relative to the overall population or gross domestic product (GDP) (see table) .
It seems that the countries where the greatest number of grants are obtained per capita -and hence with the most efficient young scientists -are Cyprus, Israel, Switzerland and the Netherlands. Bulgaria, which won just one grant, does better than the traditional strongholds in terms of grants in relation to GDP, and Hungary with six is in third position.
Germany Decisions on whether to fund particular projects are not scientific decisions. They are social decisions, and may therefore be over-influenced by hype. Research funding must compete with other funding needs, and research hype is up against the hype of military spending, spiralling oil costs and the latest celebrity exploits. Waiting for medical benefits to be proven before funding basic research would mean that basic research would never be funded.
Medicine is founded on germ theory, physiology, hygiene and antibiotics. Yet there are profound gaps in our understanding of those interactions. Health conditions common in the developed world (obesity, diabetes, allergies, asthma, heart, vascular and inflammatory diseases) remain rare to nonexistent in the rural undeveloped world, despite the lack of potential treatment. The 'hygiene hypothesis' tries to explain these differences, but so far no protective agent has been found. If the microbiome project can eventually deliver such an agent, or agents, and stop even a fraction of the health decline associated with economic development, the effects will still be profound.
The analogy of the microbiome with rainforest biodiversity is apt. We should exhaustively sample and understand the diversity of both in the wild before the 'clear cutting' of modern agriculture and hygiene practices irreversibly destroys them both. 578-580; 2008) highlights the potential importance of the gut microbiome in understanding health. As you discuss, human profiles differ in obese and lean individuals and are being scrutinized for their possible influence on weight.
A factor you don't mention is the routine administration over some 50 years of antibiotics and probiotics as growth promoters to farm animals. Use of antibiotics for this purpose was banned in 2005 in the European Union, but it continues in many places (including the United States).
Compounds with antibiotic activity and bacteria with probiotic activity have been widely tested as growth promoters (see, for example, M. Khan et al. Brit. Poultry Sci. 48, 732-735; 2007) . The probiotics used in agricultural industries are mainly Lactobacillus
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